Fundamental dimension Equity attribute | XYZLeader $76.46▼-3.24% Cap $45.94BP/E 134.1x QuantScore58/100 | ADYEYPeer $10.53▼-1.96% Cap $33.24BP/E 26.5x QuantScore51/100 | FISVPeer $49.86▼-1.89% Cap $26.51BP/E 9.6x QuantScore53/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
79/100 |
63/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 31/100 | 45/100 | 100/100 |
Health Piotroski, Altman Z, leverage & liquidity | 68/100 | 87/100 | 27/100 |
Growth Revenue / earnings growth & margins | 26/100 | 59/100 | 26/100 |
Sentiment Analyst ratings, targets & revisions | 85/100 | 0/100 | 36/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 134.1x | 26.5x | 9.6x |
Forward P/E (next FY) | 18.8x | 23.9x | 6.9x |
EV / EBITDA (TTM) | 31.9x | 10.9x | 7.2x |
Price / Sales | 1.8x | 10.4x | 1.3x |
Price / Free Cash Flow | 11.8x | 59.3x | 6.8x |
PEG ratio | -1.52 | 2.21 | -0.73 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 7 / 9 | 6 / 9 |
Altman Z-Score | 2.89 (Grey) | 4.06 (Safe) | 1.23 (Distress) |
Total debt / equity | 0.33 | 0.07 | 1.04 |
Quick ratio | 2.2x | 186.8x | 1.0x |
Interest coverage | 12.9x | 136.7x | 2.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +0.3% | +15.3% | +3.6% |
Net income growth YoY | -54.9% | +10.3% | +11.1% |
Gross margin (TTM) | 46.4% | 78.7% | 47.2% |
Operating margin (FY) | 12.6% | 41.5% | 26.9% |
FCF margin (FY) | 10.0% | 35.2% | 20.3% |
5. Trailing price performancePrice change over period |
1M return | +2.4% | +9.1% | +8.4% |
3M return | -0.0% | +16.9% | -2.3% |
6M return | +9.3% | -8.0% | -18.0% |
Year to date | +17.5% | -34.1% | -25.8% |
1Y return | -2.7% | -40.1% | -60.2% |
3Y return | +74.2% | +44.1% | -56.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $29.35 -61.6% premium | $8.18 -22.3% premium | $311.65 +525.0% upside |
Wall Street consensus target | $98.06 +28.3% · range $75.00–$115.00 | — — | $61.77 +23.9% · range $46.00–$91.00 |
Consensus stance | 77% Buy21% Hold3% Sell | 0% Buy100% Hold0% Sell | 54% Buy46% Hold0% Sell |